CVS Health Corp (CVS)
69.45
+2.74 (4.11%)
NYSE · Last Trade: May 1st, 9:45 PM EDT
Detailed Quote
Previous Close | 66.71 |
---|---|
Open | 72.50 |
Bid | 69.58 |
Ask | 69.69 |
Day's Range | 69.27 - 72.51 |
52 Week Range | 43.56 - 72.51 |
Volume | 20,880,179 |
Market Cap | 91.64B |
PE Ratio (TTM) | 18.92 |
EPS (TTM) | 3.7 |
Dividend & Yield | 2.660 (3.83%) |
1 Month Average Volume | 11,939,630 |
Chart
About CVS Health Corp (CVS)
CVS Health Corp is a diversified healthcare company that operates a vast network of retail pharmacies, providing prescription medications, over-the-counter products, and health and wellness services. In addition to its retail operations, CVS Health also offers pharmacy benefit management services, helping manage prescription drug costs for businesses and health plans. The company is involved in providing health insurance and health services through its various divisions, including a growing presence in digital health solutions and immunization services. By integrating pharmacy services with healthcare delivery, CVS Health aims to enhance patient care and improve health outcomes across the communities it serves. Read More
News & Press Releases
Let's have a look at the top S&P500 gainers and losers one hour before the close of the markets of today's session.
Via Chartmill · May 1, 2025
Stay updated with the movements of the S&P500 index in the middle of the day on Thursday. Discover which stocks are leading as top gainers and losers in today's session.
Via Chartmill · May 1, 2025
Wegovy to become preferred GLP-1 drug on CVS Caremark's top formularies in 2025 as Novo Nordisk expands patient access initiatives.
Via Benzinga · May 1, 2025
Curious about the S&P500 stocks that are gapping on Thursday? Explore the gap up and gap down stocks in the S&P500 index during today's session.
Via Chartmill · May 1, 2025
Wall Street pushed higher in midday trading, with the S&P 500 on track for its eighth consecutive gain — its longest winning streak since November 2023. The index rose about 1% to 5,560, fully recovering the losses sustained after former President Donald Trump announced trade tariffs on April 2.
Via Benzinga · May 1, 2025
Via Benzinga · May 1, 2025
CVS Health topped Q1 estimates with $94.59 billion in revenue and raised 2025 EPS outlook to $6.00–$6.20 amid strong Medicare performance.
Via Benzinga · May 1, 2025
Get insights into the top gainers and losers in the S&P500 index of Thursday's pre-market session.
Via Chartmill · May 1, 2025
Diversified healthcare company CVS Health (NYSE:CVS) beat Wall Street’s revenue expectations in Q1 CY2025, with sales up 7% year on year to $94.59 billion. Its non-GAAP profit of $2.25 per share was 34.6% above analysts’ consensus estimates.
Via StockStory · May 1, 2025
The company now expects full-year adjusted EPS in the range of $6.00 to $6.20, up from its previous guidance of $5.75 to $6.00.
Via Stocktwits · May 1, 2025
Diversified healthcare company CVS Health (NYSE:CVS)
will be announcing earnings results tomorrow morning. Here’s what to expect.
Via StockStory · April 30, 2025
Jim Cramer is preparing investors for another action-packed week on Wall Street, packed with earnings reports from major tech players and key economic updates.
Via Benzinga · April 27, 2025
Elevance Health posts strong Q1 with premium, Medicare, and CarelonRx growth, reaffirming 2025 EPS guidance above Wall Street estimates.
Via Benzinga · April 22, 2025
UnitedHealthcare Group is the best house in a rough neighborhood as its still a very profitable vertically integrated healthcare company, not just an insurer.
Via MarketBeat · April 22, 2025
Via The Motley Fool · April 22, 2025
Healthcare sector sees volatility due to UnitedHealth's earnings disappointment, but ETFs like XLV, IHE, and XPH still show resilience and pockets of strength.
Via Benzinga · April 18, 2025
Curious about the market action on Thursday? Dive into the US markets to explore the gap up and gap down stocks in the S&P500 index during today's session.
Via Chartmill · April 17, 2025
CVS, Humana and Elevance shares are moving lower on Thursday after UnitedHealth reported earnings prior to the market opening.
Via Benzinga · April 17, 2025
Let's have a look at what is happening on the US markets before the opening bell on Thursday. Below you can find the top S&P500 gainers and losers in today's pre-market session.
Via Chartmill · April 17, 2025
Health insurance stocks are outperforming the benchmark indices in 2025, as these two tariff-free and recession-resistant carriers are up 16% and 54%.
Via MarketBeat · April 15, 2025
Walgreens stock might be a good name to consider in the coming months, especially as new developments might boost a takeover bid.
Via MarketBeat · April 13, 2025